Harbin Medical University

Running trials

• Active, not recruiting

  Time-Restricted Eating for Weight-Loss Maintenance

  NCT07163455· Source

• Not yet recruiting

  Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

  NCT06648525· Phase 2· Source

• Active, not recruiting

  The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer

  NCT06422702· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening

  NCT07682220· Source

• Completed

  Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR)

  NCT06726252· Source

Trial sites

• Harbin Medical University5 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Lung cancer150 works · 1 trials
• Liver and biliary tract cancer108 works · 1 trials
• Colorectal cancer105 works · 0 trials
• Gastric and esophageal cancer80 works · 1 trials
• Type 2 diabetes64 works · 0 trials
• Ovarian cancer49 works · 0 trials
• Triple-negative breast cancer42 works · 0 trials
• Bladder cancer33 works · 0 trials
• Cervical cancer29 works · 0 trials
• Kidney cancer27 works · 0 trials
• Fatty liver disease (MASLD/MASH)25 works · 0 trials
• Osteoporosis21 works · 0 trials
• Diabetic eye disease20 works · 0 trials
• Autism20 works · 0 trials
• Thyroid cancer19 works · 1 trials
• Psoriasis18 works · 0 trials
• Metastatic breast cancer15 works · 0 trials
• Endometrial cancer14 works · 0 trials
• Idiopathic pulmonary fibrosis12 works · 0 trials
• Diffuse large B-cell lymphoma10 works · 0 trials
• Myasthenia gravis7 works · 0 trials
• Follicular lymphoma4 works · 0 trials
• Sjögren's disease3 works · 0 trials